Final Project Profitability Ratios’ Analysis of Pharmaceuticals in same industry for FY 2008-10 Sanofi-Aventis Ferozsons Abbott A REPORT SUBMITTED TO THE DEPARTMENT OF MANAGEMENT SCIENCES‚ VIRTUAL UNIVERSITY OF PAKISTAN IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTERS IN BUSINESS ADMINISTRATION Submitted By Mc080402262 Sheikh Khurum Akram Department of Management Sciences‚ Virtual University of Pakistan Acknowledgement In the name of ALLAH‚
Premium Generally Accepted Accounting Principles Financial ratios Profit margin
Technology Date of submission: TRANSMITTAL LETTER The Report supervisor Md. Amdadul Haque Asst. Professor Department of Finance Bangladesh University of Business & Technology (BUBT). Subject: Submission of financial report of Renata Ltd. & Beximco Pharmaceuticals Ltd. Dear Sir It is our pleasure to present the report on Managerial Finance. Which is done for partial fulfillment of the requirement of BBA degree. As measurement we are enthusiastic to you for giving us the opportunity
Premium Financial ratios Financial ratio
business of Pharmaceutical companies:- Pharmaceutical companies are not especially big in terms of revenues‚ but they are very profitable. For instance‚ in 2001‚ Pfizer was ranked 127th in the world on total revenue (US$32·2 billion) but 7th in terms of profit.29 The pharmaceutical industry is the most profitable business sector‚ with an average 16·2% profit‚ ahead of financial companies (11·6%) and beverages (10%).30 However‚ net income growth has declined‚ and growth in the value of drug
Premium Pharmacology Profit Income
a lot of discussion about pharmaceutical companies‚ intellectual property‚ and the global AIDS epidemic. Do pharmaceutical companies have a responsibility to distribute drugs for free or low cost in developing countries? Why is intellectual property such a big deal? What impact would South Africa’s decision to levy duties on drugs in the country have on the international distribution of drugs? Was the change that provided patent protection for pharmaceutical companies an appropriate change or
Premium Generic drug Developing country Developed country
Questions for Review 1. Pharmaceutical companies do have a responsibility to distribute drugs for a low cost in developing and poorer countries. Africa’s GDP‚ and per capita income is very low so they cannot afford to buy top quality medicines. One main argument for this approach is the AIDS epidemic in Africa. A main argument against this is that the treatment for AIDS is very expensive to provide to a whole country for free. 2. The principal arguments of pharmaceutical companies that oppose making
Premium HIV World Trade Organization Pharmacology
Financial Statements: Industry Comparison University of Phoenix BSA 500: Business Systems I Instructor: May 28‚ 2007 Financial Statements: Industry Comparison More often managers are exposed to financial data and the need exists to develop knowledge and understanding of financial accounting concepts and principals. Nearly all companies prepare financial statements of some type and the complexity of those statements will vary. The analysis and interpretations of financial statements
Premium Balance sheet Income statement Financial statements
European Journal of Business and Management ISSN 2222-1905 (Paper) ISSN 2222-2839 (Online) www.iiste.org Financial Analysis of Selected Pharmaceutical Companies in Bangladesh Md. Tofael Hossain Majumder (Corresponding Author) Lecturer‚ Department of Accounting and Information Systems Comilla University‚ Comilla‚ Bangladesh. Phone: +8801816436176‚ Email: tofael_cou@yahoo.com Mohammed Mizanur Rahman Lecturer‚ School of Business and Economics Atish Dipankar University of Science and Technology
Premium Financial ratios Financial ratio Generally Accepted Accounting Principles
1 million in 2003 to $5‚033.8 million in 2004. This can viewed as a way of financing the continued operations that support Medtronic ’s success. Medtronic paid $0.23 per share to owners in 2002. This amount equaled $278.8 million. In 2003‚ the company paid $0.25 per share‚ equal to $304.2 million. In 2004‚ the shareholders were paid $0.29 per share equaling $351.5 million. These amounts show that Medtronic has been paying substantial returns to its owners‚ and they have also been increasing the
Premium Generally Accepted Accounting Principles Balance sheet Financial ratio
Course Title: Financial Accounting and Reporting Course Code: F – 504 Submitted By: Sifat Monjur Shamrat Roll: 24040 Submitted To: Samia Sultana Tani Assistant Professor Department of Finance Faculty of Business Studies University of Dhaka Date of Submission: Sunday‚ August 18‚ 2013 August 18‚ 2013 To Samia Sultana Tani Assistant Professor Department of Finance Faculty of Business Studies University of Dhaka Sub: Financial ration analysis
Premium Balance sheet Generally Accepted Accounting Principles Financial ratio
Subject: Submission of Term Paper on “Company Profile & Financial Statements” of “Sonar Bangla Insurance Limited” Dear Sir‚ With profound reference towards the dignity of yours‚ we are very happy that we have been able to submit the report you have assigned to us. The assignment was to prepare a term report on the course named “FINANCIAL ACCOUNTING-02(F-201)” as part of our academic activities. Here is the report on “Company Profile & Financial Statements of Sonar Bangla Insurance Limited“
Premium Insurance